Heart Failure

Clinical Trial Finder

Many patients with heart failure are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

Condition:   Heart Failure
Interventions:   Drug: Empagliflozin;   Drug: Placebo
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Not yet recruiting - verified February 2017

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Condition:   Heart Failure
Interventions:   Drug: Empagliflozin;   Drug: Placebo
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Not yet recruiting - verified February 2017

Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients

Conditions:   Sleep Apnea, Obstructive;   Heart Failure
Intervention:   Device: Continuous Positive Airway Pressure (CPAP)
Sponsors:   West Virginia University;   West Virginia Clinical & Translational Science Institute
Recruiting - verified February 2017

Day-care Unit for Patients With Refractory Heart Failure

Conditions:   Heart Failure;   Heart Diseases;   Cardiovascular Diseases
Intervention:   Other: treatment in day-care heart failure unit
Sponsor:   Silesian Centre for Heart Diseases
Enrolling by invitation - verified February 2017

Pathogenic Mechanisms of Cancer and Cardiovascular Diseases

Conditions:   Pathogenesis;   Cardiovascular Diseases;   Cancer
Intervention:   Diagnostic Test: micro RNA
Sponsors:   Sakakibara Heart Institute;   Japanese Foundation for Cancer Research
Recruiting - verified February 2017

A Study of the Addition of Pembrolizumab to Postoperative Radiotherapy in Resected High Risk Cutaneous Squamous Cell Cancer of the Head and Neck

Condition:   Squamous Cell Carcinoma of the Head and Neck
Interventions:   Drug: Pembrolizumab;   Radiation: IMRT 60-66Gy
Sponsor:   Case Comprehensive Cancer Center
Not yet recruiting - verified February 2017

The Impact of Depression and/or Anxiety on PCI Patients

Conditions:   Acute Coronary Syndrome;   MAjor Depressive Disorder;   Generalized Anxiety Disorder
Intervention:   Other: antidepressive and anti-anxiety therapy
Sponsors:   First Affiliated Hospital Xi'an Jiaotong University;   Shaanxi Provincial People's Hospital;   Xi'an Central Hospital;   Baoji Central Hospital;   Baoji People's Hospital;   General Hospital of Ningxia Medical University;   The People's Hospital of Ningxia;   Wuzhong People's Hospital;   The First Hospital of Lanzhou University;   LanZhou University;   First Affiliated Hospital of Xinjiang Medical University;   the People's Hospital of Xinjiang Uygur Autonomous Region;   The First People's Hospital of Kashgar Erea;   the First Division Hospital of Xinjiang Production and Construction Corps
Not yet recruiting - verified December 2016

Ephedrine and Phenylephrine for Spinal Hypotension

Condition:   Spinal Hypotension
Interventions:   Drug: Phenylephrine;   Drug: Ephedrine
Sponsor:   Assiut University
Recruiting - verified February 2017

Ferric Citrate in ESRD Pilot Project

Conditions:   End Stage Renal Disease;   Chronic Kidney Diseases
Intervention:   Drug: Ferric Citrate
Sponsors:   Sreedhar Mandayam;   Keryx Biopharmaceuticals
Recruiting - verified February 2017

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points